Navamedic ASA Statistics

Total Valuation

Navamedic ASA has a market cap or net worth of NOK 507.29 million. The enterprise value is 621.46 million.

Market Cap	507.29M
Enterprise Value	621.46M

Important Dates

The last earnings date was Thursday, August 29, 2024.

Earnings Date	Aug 29, 2024
Ex-Dividend Date	n/a

Share Statistics

Navamedic ASA has 17.43 million shares outstanding. The number of shares has increased by 2.58% in one year.

Shares Outstanding	17.43M
Shares Change (YoY)	+2.58%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.92%
Owned by Institutions (%)	43.52%
Float	12.65M

Valuation Ratios

The trailing PE ratio is 21.02 and the forward PE ratio is 15.48.

PE Ratio	21.02
Forward PE	15.48
PS Ratio	0.93
PB Ratio	2.08
P/FCF Ratio	161.76
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.36, with an EV/FCF ratio of 198.17.

EV / Earnings	25.22
EV / Sales	1.14
EV / EBITDA	9.36
EV / EBIT	12.14
EV / FCF	198.17

Financial Position

The company has a current ratio of 1.44, with a Debt / Equity ratio of 58.37.

Current Ratio	1.44
Quick Ratio	0.61
Debt / Equity	58.37
Debt / EBITDA	2.15
Debt / FCF	45.43
Interest Coverage	5.03

Financial Efficiency

Return on equity (ROE) is 10.82% and return on invested capital (ROIC) is 8.75%.

Return on Equity (ROE)	10.82%
Return on Assets (ROA)	6.38%
Return on Capital (ROIC)	8.75%
Revenue Per Employee	12.08M
Profits Per Employee	547,533
Employee Count	45
Asset Turnover	1.08
Inventory Turnover	3.60

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.63% in the last 52 weeks. The beta is 0.48, so Navamedic ASA's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	-9.63%
50-Day Moving Average	31.88
200-Day Moving Average	35.03
Relative Strength Index (RSI)	38.02
Average Volume (20 Days)	19,339

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Navamedic ASA had revenue of NOK 543.49 million and earned 24.64 million in profits. Earnings per share was 1.38.

Revenue	543.49M
Gross Profit	217.60M
Operating Income	51.20M
Pretax Income	34.39M
Net Income	24.64M
EBITDA	64.01M
EBIT	51.20M
Earnings Per Share (EPS)	1.38

Full Income Statement

Balance Sheet

The company has 28.32 million in cash and 142.48 million in debt, giving a net cash position of -114.16 million or -6.55 per share.

Cash & Cash Equivalents	28.32M
Total Debt	142.48M
Net Cash	-114.16M
Net Cash Per Share	-6.55
Equity (Book Value)	244.10M
Book Value Per Share	14.00
Working Capital	88.89M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.61 million and capital expenditures -2.47 million, giving a free cash flow of 3.14 million.

Operating Cash Flow	5.61M
Capital Expenditures	-2.47M
Free Cash Flow	3.14M
FCF Per Share	0.18

Full Cash Flow Statement

Margins

Gross margin is 40.04%, with operating and profit margins of 9.42% and 4.53%.

Gross Margin	40.04%
Operating Margin	9.42%
Pretax Margin	6.33%
Profit Margin	4.53%
EBITDA Margin	11.78%
EBIT Margin	9.42%
FCF Margin	0.58%

Dividends & Yields

Navamedic ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.58%
Shareholder Yield	-2.58%
Earnings Yield	4.76%
FCF Yield	0.62%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a